GlassScriptPhysician profile
Aaron C Macdonald
NPI 1649282245
$1,522.89
in general payments reported to CMS, 2019-2025
12 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $585 · 2020: $25.31 · 2021: $117 · 2022: $204 · 2023: $125 · 2024: $363 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $407 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $407.27 |
| Education | $184.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Brainlab, INC. | $455.50 | 2019 | |
| Depuy Synthes Sales INC. | $402.85 | 2019-2025 | Vivigen Mis Delivery System, Symphony, Viper |
| Cerapedics INC. | $184.17 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Abbott Laboratories | $113.54 | 2019-2024 | Penta, Eterna |
| Globus Medical, INC. | $89.82 | 2022 | |
| Nevro Corp. | $70.72 | 2019-2024 | Senza |
| Medtronic, INC. | $61.30 | 2024-2025 | Vanta Adaptivestim, Aquamantys(Tm), Inceptiv |
| Stryker Corporation | $41.76 | 2023-2024 | Everest Spinal System |
| Boston Scientific Corporation | $41.06 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $22.97 | 2024 | Andexxa |
| Vertex Pharmaceuticals Incorporated | $20.48 | 2025 | |
| Heron Therapeutics, INC. | $18.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Macdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.